Summary Slide.png (101.55 kB)

Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study

Download (101.55 kB)
posted on 31.03.2020 by Ken Yoshikawa, Akira Tsuchiya, Tomoyuki Kido, Tomohiro Ota, Keiko Ikeda, Mika Iwakura, Yoshikazu Maeda, Shinichiroh Maekawa

The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC. 2020.